The store will not work correctly when cookies are disabled.
(E)-6-(4-chlorostyryl)-4-hydroxypyridazin-3(2H)-one
ID: ALA2338791
PubChem CID: 71655534
Max Phase: Preclinical
Molecular Formula: C12H9ClN2O2
Molecular Weight: 248.67
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]nc(/C=C/c2ccc(Cl)cc2)cc1O
Standard InChI: InChI=1S/C12H9ClN2O2/c13-9-4-1-8(2-5-9)3-6-10-7-11(16)12(17)15-14-10/h1-7H,(H,14,16)(H,15,17)/b6-3+
Standard InChI Key: QONXDCNKLRKZKF-ZZXKWVIFSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
38.3502 -8.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3502 -9.1047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.0596 -9.5091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.7690 -9.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7690 -8.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0596 -7.8665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4803 -9.5143 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.4821 -7.8727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6372 -7.8727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9265 -8.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2176 -7.8768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2192 -7.0565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5070 -6.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7954 -7.0608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8004 -7.8864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5132 -8.2932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0818 -6.6552 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
5 8 1 0
1 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 248.67 | Molecular Weight (Monoisotopic): 248.0353 | AlogP: 2.30 | #Rotatable Bonds: 2 |
Polar Surface Area: 65.98 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.40 | CX Basic pKa: ┄ | CX LogP: 2.42 | CX LogD: 2.12 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.86 | Np Likeness Score: -0.55 |
References
1. Hondo T, Warizaya M, Niimi T, Namatame I, Yamaguchi T, Nakanishi K, Hamajima T, Harada K, Sakashita H, Matsumoto Y, Orita M, Takeuchi M.. (2013) 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors., 56 (9): [PMID:23566269] [10.1021/jm400095b] |